|
[1]PROSSER DE,JONES G.Enzymes involved in the activation and inactivation of vitamin D[J].Trends Biochem Sci,2004,29(12):664-673.
|
|
[2] CHANG EJ,YI DY,YANG HR.Vitamin D status and bone mineral density in obese children with nonalcoholic fatty liver disease[J].J Korean Med Sci,2015,30(12):1821-1827.
|
|
[3]KONG J,DING Y,ZHANG C,et al.Severe vitamin D-deficiency and increased bone turnover in patients with hepatitis B from northeastern China[J].Endocr Res,2013,38(4):215-222.
|
|
[4]YU LL,YIN LY,CHEN W,et al.Prospective study on the relation between serum vitamin D levels and liver cirrhosis risk[J].Chin J Hepatol,2013,21(3):202-206.(in Chinese)于露露,尹梁宇,陈汶,等.维生素D与肝硬化发病风险关系的前瞻性研究[J].中华肝脏病杂志,2013,21(3):202-206.
|
|
[5]AGMON-LEVIN N,KOPILOV R,SELMI C,et al.Vitamin D in primary biliary cirrhosis,a plausible marker of advanced disease[J].Immunol Res,2015,61(1-2):141-146.
|
|
[6] SAVIC Z,DAMJANOV D,CURIC N,et al.Vitamin D status,bone metabolism and bone mass in patients with alcoholic liver cirrhosis[J].Bratisl Lek Listy,2014,115(9):573-578.
|
|
[7] AVIHINGSANON A,APORNPONG T,RAMAUTARSING RA,et al.Decline in serum 25 hydroxyvitamin D levels in HIV-HBV-coinfected patients after long-term antiretroviral therapy[J].Antivir Ther,2014,19(1):41-49.
|
|
[8] ANDRESS DL.Vitamin D in chronic kidney disease:a systemic role for selective vitamin D receptor activation[J].Kidney Int,2006,69(1):33-43.
|
|
[9]GRNHAGE F,HOCHRATH K,KRAWCZYK M,et al.Common genetic variation in vitamin D metabolism is associated with liver stiffness[J].Hepatology,2012,56(5):1883-1891.
|
|
[10]BAUR K,MERTENS JC,SCHMITT J,et al.Combined effect of25-OH vitamin D plasma levels and genetic vitamin D receptor(NR 1I1)variants on fibrosis progression rate in HCV patients[J].Liver Int,2012,32(4):635-643.
|
|
[11] ZOLLNER G,MARSCHALL HU,WAGNER M,et al.Role of nuclear receptors in the adaptive response to bile acids and cholestasis:pathogenetic and therapeutic considerations[J].Mol Pharm,2006,3(3):231-251.
|
|
[12]KEMPIN'SKA-PODHORECKA A,WUNSCH E,JAROWICZ T,et al.Vitamin D receptor polymorphisms predispose to primary biliary cirrhosis and severity of the disease in polish population[J].Gastroenterol Res Pract,2012,2012:408723.
|
|
[13]LI YJ,TANG YW,SHI YQ,et al.Polymorphisms in the vitamin Dreceptor gene and risk of primary biliary cirrhosis:a meta-analysis[J].J Gastroenterol Hepatol,2014,29(4):706-715.
|
|
[14]MO C,LU Y,DENG Y,et al.Lack of association between vitamin D receptor gene ApaI,BsmI,and Taq I polymorphisms and primary biliary cirrhosis risk:a meta-analysis[J].Tumour Biol,2014,35(5):4913-4920.
|
|
[15]YAGN WM,XIN GJ,DING SN.Levels and clinical significance of serum 25-hydroxy vitamin D in patients with chronic liver disease[J].J Clin Hepatol,2015,31(5):754-757.(in Chinese)杨伟民,辛桂杰,丁胜楠.慢性肝病患者血清25-羟维生素D水平及临床意义[J].临床肝胆病杂志,2015,31(5):754-757.
|
|
[16] COSTA SM,EROTIDES ST,de ALENTAR ML,et al.Factors associated with 25-hydroxyvitamin D levels in patients with liver cirrhosis[J].Ann Hepatol,2015,14(1):99-107.
|
|
[17]MALHAM M,PETER JS,LAURIDSEN AL,et al.The effect of a single oral megadose of vitamin D provided as either ergocalciferol(D)or cholecalciferol(D)in alcoholic liver cirrhosis[J].Eur JGastroenterol Hepatol,2012,24(2):172-178.
|
|
[18] ZHANG C,ZHAO L,MA L,et al.Vitamin D status and expression of vitamin D receptor and LL-37 in patients with spontaneous bacterial peritonitis[J].Dig Dis Sci,2012,57(1):182-188.
|
|
[19]TERRIER B,CARRAT F,GERI G,et al.Low 25-OH vitamin Dserum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis[J].J Hepatol,2011,55(4):756-761.
|
|
[20] STOKES CS,KRAWCZYK M,REICHEL C,et al.Vitamin D deficiency is associated with mortality in patients with advanced liver cirrhosis[J].Eur J Clin Invest,2014,44(2):176-183.
|
|
[21]FINKELMEIER F,KRONENBERGER B,KBERLE V,et al.Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma-a prospective cohort study[J].Aliment Pharmacol Ther,2014,39(10):1204-1212.
|
|
[22] QUINTERO-PLATT G,GONZLEZ-REIMERS E,MARTN-GONZLEZ MC,et al.Vitamin D,vascular calcification and mortality among alcoholics[J].Alcohol Alcohol,2015,50(1):18-23.
|
|
[23]ZOU JH,KONG XJ,LI CY,et al.Evaluation of neutrophilic CD64index and CD32 index as a diagnostic marker of liver cirrhosis with spontaneous bacterial peritonitis in early stage[J].Chin J Immunol,2015,31(6):827-830.(in Chinese)邹金海,孔祥军,李春英,等.中性粒细胞CD64、CD32指数在肝硬化并自发性细菌性腹膜炎诊断中的价值[J].中国免疫学杂志,2015,31(6):827-830.
|
|
[24] ANTY R,TONOHOUAN M,FERRARI-PANAIA P,et al.Low levels of 25-hydroxy vitamin D are independently associated with the risk of bacterial infection in cirrhotic patients[J].Clin Transl Gastroenterol,2014,5:e56.
|
|
[25]XIE XX,YANG G,YANG CY.Effect of supplementation vitamin d on inflammation and intestinal permeability in patients with liver cirrhosis[J].Chin J Modern Appl Pharm,2015,32(8):1020-1023.(in Chinese)谢肖肖,林刚,杨纯英.维生素D对肝硬化患者炎症及肠道通透性的影响[J].中国现代应用药学,2015,32(8):1020-1023.
|
|
[26]TRPO E,OUZIEL R,PRADAT P,et al.Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease[J].J Hepatol,2013,59(2):344-350.
|
|
[27]DEB S,CHIN MY,ADOMAT H,et al.Ginsenoside-mediated blockade of 1α,25-dihydroxyvitamin D3 inactivation in human liver and intestine in vitro[J].J Steroid Biochem Mol Biol,2014,141:94-103.
|
|
[28]FALLETI E,BITETTO D,FABRIS C,et al.Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis[J].World J Gastroenterol,2010,16(24):3016-3024.
|
|
[29]YAO X,ZENG H,ZHANG G,et al.The associated ion between the VDR gene polymorphisms and susceptibility to hepatocellular carcinoma and the clinicopathological features in subjects infected with HBV[J].Biomed Res Int,2013,2013:953974.
|
|
[30]HAMMAD LN,ABDELRAOUF SM,HASSANEIN FS,et al.Circulating IL-6,IL-17 and vitamin D in hepatocellular carcinoma:potential biomarkers for a more favorable prognosis?[J].J Immunotoxicol,2013,10(4):380-386.
|
|
[31]FARNIK H,BOJUNGA J,BERGER A,et al.Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients[J].Hepatology,2013,58(4):1270-1276.
|
|
[32]SCHAALAN MF,MOHAMED WA,AMIN HH.Vitamin D deficiency:correlation to interleukin-17,interleukin-23 and PIIINPin hepatitis C virus genotype 4[J].World J Gastroenterol,2012,18(28):3738-3744.
|
|
[33]AMANZADA A,GORALCZYK AD,MORICONI F,et al.Vitamin D status and serum ferritin concentration in chronic hepatitis C virus type 1 infection[J].J Med Virol,2013,85(9):1534-1541.
|
|
[34]GARCA-LVAREZ M,PINEDA-TENOR D,JIMNEZ-SOUSAMA,et al.Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy:a meta-analysis[J].Hepatology,2014,60(5):1541-1550.
|
|
[35]MAHAMID M,NSEIR W,ABU ELHIJA O,et al.Normal vitamin D levels are associated with spontaneous hepatitis B surface antigen seroclearance[J].World J Hepatol,2013,5(6):328-331.
|
|
[36]ABU-MOUCH S,FIREMAN Z,JARCHOVSKY J,et al.Vitamin D supplementation improves sustained virologic response in chronic hepatitis C(genotype 1)-nave patients[J].World J Gastroenterol,2011,17(47):5184-5190.
|
|
[37]NIMER A,MOUCH A.Vitamin D improves viral response in hepatitis C genotype 2-3 nave patients[J].World J Gastroenterol,2012,18(8):800-805.
|
|
[38] REFAAT B,EL-SHEMI AG,ASHSHI A,et al.Vitamin D and chronic hepatitis C:effects on success rate and prevention of side effects associated with pegylated interferon-αand ribavirin[J].Int J Clin Exp Med,2015,8(7):10284-10303.
|
|
[39]EFE C,KAV T,AYDIN C,et al.Low serum vitamin D levels are associated with severe histological features and poor response to therapy in patients with autoimmune hepatitis[J].Dig Dis Sci,2014,59(12):3035-3042.
|
|
[40]GUO GY,SHI YQ,WANG L,et al.Serum vitamin D level is associated with disease severity and response to ursodeoxycholic acid in primary biliary cirrhosis[J].Aliment Pharmacol Ther,2015,42(2):221-230.
|
|
[41] BEILFUSS A,SOWA JP,SYDOR S,et al.Vitamin D counteracts fibrogenic TGF-βsignalling in human hepatic stellate cells both receptor-dependently and independently[J].Gut,2015,64(5):791-799.
|
|
[42] ABRAMOVITCH S,DAHAN-BACHAR L,SHARVIT E,et al.Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats[J].Gut,2011,60(12):1728-1737.
|
|
[43] SEYDEL S,BEILFUSS A,KAHRAMAN A,et al.Vitamin D ameliorates stress ligand expression elicited by free fatty acids in the hepatic stellate cell line LX-2[J].Turk J Gastroenterol,2011,22(4):400-407.
|
|
[44]LEE PC,YANG YY,LEE WP,et al.Comparative portal hypotensive effects as propranolol of vitamin D treatment by decreasing intrahepatic resistance in cirrhotic rats[J].J Gastroenterol Hepatol,2015,30(3):628-637.
|
|
[45]HOCHRATH K,STOKES CS,GEISEL J,et al.Vitamin D modulates biliary fibrosis in ABCB4-deficient mice[J].Hepatol Int,2014,8(3):443-452.
|
|
[46]REITER FP,HOHENESTER S,NAGEL JM,et al.1,25-(OH)-vitamin D prevents activation of hepatic stellate cells in vitro and ameliorates inflammatory liver damage but not fibrosis in the Abcb4(-/-)model[J].Biochem Biophys Res Commun,2015,459(2):227-233.
|
|
[47] ZHU L,KONG M,HAN YP,et al.Spontaneous liver fibrosis induced by long term dietary vitamin D deficiency in adult mice is related to chronic inflammation and enhanced apoptosis[J].Can JPhysiol Pharmacol,2015,93(5):385-394.
|
|
[48] ABRAMOVITCH S,SHARVIT E,WEISMAN Y,et al.Vitamin Dinhibits development of liver fibrosis in an animal model but cannot ameliorate established cirrhosis[J].Am J Physiol Gastrointest Liver Physiol,2015,308(2):g112-g120.
|
|
[49]REN Y,LIU M,ZHAO J,et al.Serum vitamin D does not correlate with liver fibrosis in chronic hepatitis C[J].World J Gastroenterol,2015,21(39):11152-11159.
|
|
[50]SCHWARTZ JB,LAI J,LIZAOLA B,et al.Variability in free 25(OH)vitamin D levels in clinical populations[J].J Steroid Biochem Mol Biol,2014,144 Pt A:156-158.
|
DownLoad: